Welcome back to the BBAE Blog, your trusted source for the latest investment insights and analyses from the BBAE team. This week, we’re excited to share some highlights that will keep you informed and ahead of the market. Don’t forget, some of our most valuable insights are available exclusively in the BBAE Pro app—download it now to unlock full access!
- Nvidia’s Q4 2025 Portfolio Breakdown
- KKR & Co. Inc. ($KKR) Insider Buying After Recent Pullback
- Trending Tickers: $HYMC Resource Boost, $META & $NVDA AI Deal, $IBRX EU Approval
Need a reminder of why BBAE? We have one goal: to provide you with exclusive content and data to help you make informed investing decisions. Explore a wealth of market insights and potential investing opportunities that you can’t find anywhere else.
Nvidia’s Q4 2025 Portfolio Breakdown
Nvidia’s latest 13F filing offers a fresh look at how the company has been reshaping its publicly disclosed investment portfolio, revealing a concentrated set of major holdings tied closely to the computing and AI infrastructure ecosystem. As of December 31, 2025, some of its largest reported positions include $INTC, $SNPS, and $NOK, while the filing also shows that Nvidia exited several prior investments during the quarter, signaling a shift in where it’s allocating capital. Many of these newly disclosed stakes were not surprises to the market, since Nvidia had already announced partnerships or strategic deals with some of the companies earlier in 2025. Overall, the filing provides a snapshot of how Nvidia’s public equity exposure aligns with sectors connected to semiconductors, software, networking, and large-scale computing. Read the full article here.
KKR & Co. Inc. ($KKR) Insider Buying After Recent Pullback
Scott Nuttall and Joseph Bae, Co-Chief Executive Officers at KKR ($KKR), disclosed notable insider buying activity, with Nuttall purchasing a combined 250,000 shares for about $25.6 million in his largest buys on record and Bae also acquiring shares around a similar price range. A director separately purchased 43,872 shares worth roughly $4.51 million, increasing their stake by more than 44%. Overall, four insiders have reported four purchases within the past 30 days, while the stock had declined about 21.7% during the month prior to the reported activity. You can track insider activity like this daily with InsiderEdge, available in the BBAE app.
Trending Tickers: $HYMC Resource Boost, $META & $NVDA AI Deal, $IBRX EU Approval
This week, several stocks attracted attention due to major developments. Here’s a breakdown:
- Hycroft ($HYMC): Hycroft reported a 55% increase in measured and indicated gold and silver resources at its Nevada mine, now totaling 16.4M ounces of gold and 562.6M ounces of silver. The company said improved drilling, modeling, and metallurgy drove the update. Test results showed solid recovery rates, and management is evaluating processing options that could further improve project economics. Shares jumped 21% on the news.
- Meta ($META) & NVIDIA ($NVDA): Meta and NVIDIA announced a multiyear AI infrastructure partnership. Meta plans to deploy millions of NVIDIA Blackwell and Rubin GPUs, along with new CPUs and networking systems, to support large-scale AI training and inference. The companies said the collaboration will power next-generation AI services across Meta’s platforms. The stocks showed little immediate reaction.
- ImmunityBio ($IBRX): ImmunityBio received conditional approval from the European Commission for its bladder cancer immunotherapy combined with BCG. According to the company, this is the first approved immunotherapy in Europe for this specific type of early-stage bladder cancer. Clinical data showed a 71% complete response rate. Shares surged 41% following the announcement.
Read the full Weekly Highlights article here.
This article is for informational purposes only and is neither investment advice nor a solicitation to buy or sell securities. All investment involves inherent risks, including the total loss of principal, and past performance is not a guarantee of future results. Always conduct thorough research or consult with a financial expert before making any investment decisions. BBAE has no position in any investment mentioned.
